Total Sleep Duration and Risk of Type 2 Diabetes: Evidence-Based On Clinical and Epidemiological Studies

E-ISSN： 1875-5453|19|12|979-985

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.19, Iss.12, 2018-10, pp. : 979-985

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biphasic Insulin Aspart in Type 2 Diabetes Mellitus: An Evidence-Based Medicine Review

By Gough S.C.L.

Clinical Drug Investigation, Vol. 27, Iss. 5, 2007-01 ,pp. : 299-324

Adis International

Access to resources Recommend Favorite

Thiazolidinediones in Type 2 Diabetes Mellitus: Current Clinical Evidence

By Diamant M. Heine R.J.

Drugs, Vol. 63, Iss. 13, 2003-01 ,pp. : 1373-1405

Adis International

Access to resources Recommend Favorite

Clinical success with pharmacist-based type 2 diabetes programme

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Clinical Trials and Evidence-Based Medicine

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Extending the evidence for exenatide in type 2 diabetes

Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite